MCF Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $440K | Buy |
1,139
+60
| +6% | +$22.3K | 0.02% | 307 |
|
|
2026
Q1 | $316K | Buy |
1,079
+35
| +3% | +$11.5K | 0.01% | 324 |
|
|
2025
Q4 | $366K | Buy |
1,044
+777
| +291% | +$263K | 0.02% | 227 |
|
|
2025
Q3 | $86.3K | Buy |
267
+8
| +3% | +$2.49K | 0.01% | 346 |
|
|
2025
Q2 | $101K | Sell |
259
-7
| -3% | -$2.82K | 0.01% | 308 |
|
|
2025
Q1 | $116K | Buy |
266
+7
| +3% | +$2.81K | 0.01% | 283 |
|
|
2024
Q4 | $95.4K | Sell |
259
-1
| -0.4% | -$418 | 0.01% | 314 |
|
|
2024
Q3 | $135K | Hold |
260
| – | – | 0.01% | 277 |
|
|
2024
Q2 | $141K | Buy |
260
+15
| +6% | +$7.93K | 0.01% | 270 |
|
|
2024
Q1 | $127K | Buy |
245
+2
| +0.8% | +$995 | 0.01% | 278 |
|
|
2023
Q4 | $115K | Hold |
243
| – | – | 0.01% | 282 |
|
|
2023
Q3 | $106K | Buy |
243
+133
| +121% | +$60.3K | 0.01% | 279 |
|
|
2023
Q2 | $48.9K | Hold |
110
| – | – | ﹤0.01% | 360 |
|
|
2023
Q1 | $50.5K | Buy |
110
+75
| +214% | +$35.7K | ﹤0.01% | 349 |
|
|
2022
Q4 | $17.8K | Hold |
35
| – | – | ﹤0.01% | 465 |
|
|
2022
Q3 | $16K | Sell |
35
-48
| -58% | -$23K | ﹤0.01% | 493 |
|
|
2022
Q2 | $40K | Buy |
83
+1
| +1% | +$495 | ﹤0.01% | 346 |
|
|
2022
Q1 | $41K | Buy |
+82
| New | +$37.5K | ﹤0.01% | 356 |
|
|
2021
Q4 | – | Sell |
-114
| Closed | -$43K | – | 234 |
|
|
2021
Q3 | $43K | Hold |
114
| – | – | ﹤0.01% | 320 |
|
|
2021
Q2 | $44K | Hold |
114
| – | – | ﹤0.01% | 304 |
|
|
2021
Q1 | $41K | Sell |
114
-40
| -26% | -$12.9K | ﹤0.01% | 288 |
|
|
2020
Q4 | $49K | Hold |
154
| – | – | 0.01% | 241 |
|
|
2020
Q3 | $41K | Hold |
154
| – | – | 0.01% | 257 |
|
|
2020
Q2 | $40K | Hold |
154
| – | – | 0.01% | 242 |
|
|
2020
Q1 | $35K | Sell |
154
-79
| -34% | -$21.5K | 0.01% | 259 |
|
|
2019
Q4 | $71K | Hold |
233
| – | – | 0.01% | 217 |
|
|
2019
Q3 | $56K | Hold |
233
| – | – | 0.01% | 227 |
|
|
2019
Q2 | $66K | Buy |
233
+200
| +606% | +$54.6K | 0.01% | 210 |
|
|
2019
Q1 | $10K | Sell |
33
-20
| -38% | -$5.78K | ﹤0.01% | 344 |
|
|
2018
Q4 | $14K | Hold |
53
| – | – | ﹤0.01% | 322 |
|
|
2018
Q3 | $15K | Hold |
53
| – | – | ﹤0.01% | 320 |
|
|
2018
Q2 | $13K | Hold |
53
| – | – | ﹤0.01% | 313 |
|
|
2018
Q1 | $12K | Sell |
53
-21
| -28% | -$4.93K | ﹤0.01% | 318 |
|
|
2017
Q4 | $17K | Hold |
74
| – | – | ﹤0.01% | 306 |
|
|
2017
Q3 | $14K | Hold |
74
| – | – | ﹤0.01% | 321 |
|
|
2017
Q2 | $14K | Hold |
74
| – | – | ﹤0.01% | 340 |
|
|
2017
Q1 | $12K | Buy |
74
+1
| +1% | +$159 | ﹤0.01% | 341 |
|
|
2016
Q4 | $11K | Sell |
73
-1
| -1% | -$134 | ﹤0.01% | 303 |
|
|
2016
Q3 | $9K | Buy |
74
+1
| +1% | +$129 | ﹤0.01% | 328 |
|
|
2016
Q2 | $10K | Buy |
73
+51
| +232% | +$6.98K | ﹤0.01% | 344 |
|
|
2016
Q1 | $3K | Hold |
22
| – | – | ﹤0.01% | 393 |
|
|
2015
Q4 | $3K | Sell |
22
-618
| -97% | -$85.1K | ﹤0.01% | 407 |
|
|
2015
Q3 | $90K | Buy |
+640
| New | +$96.2K | 0.02% | 143 |
|
|
2014
Q3 | – | Sell |
-52
| Closed | -$5K | – | 447 |
|
|
2014
Q2 | $5K | Buy |
+52
| New | +$5.36K | ﹤0.01% | 353 |
|
Other funds holding ELV
MCF Advisors's ELV Position: Q2 2026 in Review
MCF Advisors increased its Elevance Health (ELV) stake by 5.6% in Q2 2026, buying an estimated $22.3K and bringing the position to 1,139 shares worth $440K. The position accounts for 0.02% of the portfolio, ranked #307.
MCF Advisors first reported a position in ELV in Q2 2014 and has held it in 44 quarters since. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- MCF Advisors held 1,139 shares of Elevance Health worth $440K as of Q2 2026.
- MCF Advisors bought 60 Elevance Health shares in Q2 2026, an estimated $22.3K.
- Elevance Health made up 0.02% of MCF Advisors's portfolio in Q2 2026, its #307 holding.
- MCF Advisors first reported a position in Elevance Health in Q2 2014 and has held it in 44 quarters since.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on MCF Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.